Literature DB >> 19665080

Severe community-acquired pneumonia.

Marcos I Restrepo1, Antonio Anzueto.   

Abstract

Community-acquired pneumonia (CAP) is the leading cause of death from infectious diseases in the United States. It accounts for 500,000 hospitalizations and 45,000 deaths each year, and it represents one of the most common causes of ICU admission. The mortality rate due to severe CAP has shown little improvement over the past few years, with rates as high as 58% when patients were admitted to the ICU. Significant interest has focused on the sickest patients who have pneumonia treated in the ICU, regarding identification of need for ICU admission and therapies directed to improve outcomes in patients who have severe CAP. This article reviews epidemiologic, microbiologic, therapeutic, preventive, and outcomes data in patients who have CAP in the ICU.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665080     DOI: 10.1016/j.idc.2009.04.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  26 in total

1.  Septic shock from community-onset pneumonia: is there a role for aspirin plus macrolides combination?

Authors:  Marco Falcone; Alessandro Russo; Alessio Farcomeni; Filippo Pieralli; Vieri Vannucchi; Vincenzo Vullo; Francesco Violi; Mario Venditti
Journal:  Intensive Care Med       Date:  2015-11-19       Impact factor: 17.440

2.  A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Yuichiro Shindo; Alessio Farcomeni; Filippo Pieralli; Roberto Cangemi; Jinliang Liu; Jingyan Xia; Junya Okumura; Masahiro Sano; Christopher Jones; Vieri Vannucchi; Massimo Mancone; Scott Micek; Feng Xu; Francesco Violi; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure.

Authors:  Andres Carrillo; Gumersindo Gonzalez-Diaz; Miquel Ferrer; Maria Elena Martinez-Quintana; Antonia Lopez-Martinez; Noemi Llamas; Maravillas Alcazar; Antoni Torres
Journal:  Intensive Care Med       Date:  2012-02-09       Impact factor: 17.440

4.  CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.

Authors:  Q Guo; H-Y Li; Y-P Zhou; M Li; X-K Chen; H Liu; H-L Peng; H-Q Yu; X Chen; N Liu; L-H Liang; Q-Z Zhao; M Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-18       Impact factor: 3.267

5.  Corticosteroids in the treatment of severe community-acquired pneumonia.

Authors:  Tasha D Ramsey; Sean K Gorman
Journal:  Curr Infect Dis Rep       Date:  2014-05       Impact factor: 3.725

6.  Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.

Authors:  Elena Laserna; Oriol Sibila; Patrick R Aguilar; Eric M Mortensen; Antonio Anzueto; Jose M Blanquer; Francisco Sanz; Jordi Rello; Pedro J Marcos; Maria I Velez; Nivin Aziz; Marcos I Restrepo
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

Review 7.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

8.  Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.

Authors:  Oriol Sibila; G Umberto Meduri; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Juan F Fernandez; Ali El-Sohl; Marcos I Restrepo
Journal:  J Crit Care       Date:  2012-12-21       Impact factor: 3.425

9.  Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque.

Authors:  Guy Zinman; Rachel Brower-Sinning; Chineye H Emeche; Jason Ernst; Grace Tzu-Wei Huang; Shaun Mahony; Amy J Myers; Dawn M O'Dee; JoAnne L Flynn; Gerard J Nau; Ted M Ross; Russell D Salter; Panayiotis V Benos; Ziv Bar Joseph; Penelope A Morel
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study.

Authors:  Jian Luo; He Yu; Yue-Hong Hu; Dan Liu; Yi-Wei Wang; Mao-Yun Wang; Bin-Miao Liang; Zong-An Liang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.